These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23886797)

  • 41. The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma.
    Huang JY; Jian ZH; Ndi Nfor O; Jhang KM; Ku WY; Ko PC; Jan SR; Ho CC; Lung CC; Pan HH; Liang YC; Liaw YP
    PLoS One; 2015; 10(7):e0133367. PubMed ID: 26196516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors and cancer recurrence associated with postoperative complications after thoracoscopic lobectomy for clinical stage I non-small cell lung cancer.
    Nakada T; Noda Y; Kato D; Shibasaki T; Mori S; Asano H; Matsudaira H; Hirano J; Odaka M; Ohtsuka T
    Thorac Cancer; 2019 Oct; 10(10):1945-1952. PubMed ID: 31436042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer.
    Moro-Sibilot D; Aubert A; Diab S; Lantuejoul S; Fourneret P; Brambilla E; Brambilla C; Brichon PY
    Eur Respir J; 2005 Sep; 26(3):480-6. PubMed ID: 16135732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group.
    Firat S; Byhardt RW; Gore E
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):357-64. PubMed ID: 12243808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lung cancer stage at diagnosis: Individual associations in the prospective VITamins and lifestyle (VITAL) cohort.
    Slatore CG; Gould MK; Au DH; Deffebach ME; White E
    BMC Cancer; 2011 Jun; 11():228. PubMed ID: 21649915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comorbidity in older surgical cancer patients: influence on patient care and outcome.
    Janssen-Heijnen ML; Maas HA; Houterman S; Lemmens VE; Rutten HJ; Coebergh JW
    Eur J Cancer; 2007 Oct; 43(15):2179-93. PubMed ID: 17681780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combining COPD with clinical, pathological and demographic information refines prognosis and treatment response prediction of non-small cell lung cancer.
    Putila J; Guo NL
    PLoS One; 2014; 9(6):e100994. PubMed ID: 24967586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599
    [No Abstract]   [Full Text] [Related]  

  • 49. Measurement and impact of co-morbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel.
    Juan O; Albert A; Campos JM; Caranyana V; Muñoz J; Alberola V
    Acta Oncol; 2007; 46(3):367-73. PubMed ID: 17450473
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does timeliness of care in Non-Small Cell Lung Cancer impact on survival?
    Vinod SK; Chandra A; Berthelsen A; Descallar J
    Lung Cancer; 2017 Oct; 112():16-24. PubMed ID: 29191589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer.
    Birim O; Maat AP; Kappetein AP; van Meerbeeck JP; Damhuis RA; Bogers AJ
    Eur J Cardiothorac Surg; 2003 Jan; 23(1):30-4. PubMed ID: 12493500
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of Charlson comorbidity index and Kaplan-Feinstein index in patients with stage I lung cancer after surgical resection.
    Wang CY; Lin YS; Tzao C; Lee HC; Huang MH; Hsu WH; Hsu HS
    Eur J Cardiothorac Surg; 2007 Dec; 32(6):877-81. PubMed ID: 17920921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Socioeconomic position and survival after lung cancer: Influence of stage, treatment and comorbidity among Danish patients with lung cancer diagnosed in 2004-2010.
    Dalton SO; Steding-Jessen M; Jakobsen E; Mellemgaard A; Østerlind K; Schüz J; Johansen C
    Acta Oncol; 2015 May; 54(5):797-804. PubMed ID: 25761702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advanced non-small cell lung cancer in the elderly: the impact of age and comorbidities on treatment modalities and patient prognosis.
    Hsu CL; Chen JH; Chen KY; Shih JY; Yang JC; Yu CJ; Yang PC
    J Geriatr Oncol; 2015 Jan; 6(1):38-45. PubMed ID: 25245172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exploring Stage I non-small-cell lung cancer: development of a prognostic model predicting 5-year survival after surgical resection†.
    Guerrera F; Errico L; Evangelista A; Filosso PL; Ruffini E; Lisi E; Bora G; Asteggiano E; Olivetti S; Lausi P; Ardissone F; Oliaro A
    Eur J Cardiothorac Surg; 2015 Jun; 47(6):1037-43. PubMed ID: 25391390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer.
    Firat S; Bousamra M; Gore E; Byhardt RW
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1047-57. PubMed ID: 11958901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of multimorbidity in short-term mortality of lung cancer patients in Spain: a population-based cohort study.
    Niksic M; Redondo-Sanchez D; Chang YL; Rodriguez-Barranco M; Exposito-Hernandez J; Marcos-Gragera R; Oliva-Poch E; Bosch-Barrera J; Sanchez MJ; Luque-Fernandez MA
    BMC Cancer; 2021 Sep; 21(1):1048. PubMed ID: 34556072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between hospital volume and mortality of patients with metastatic non-small cell lung cancer.
    Goyal G; Kommalapati A; Bartley AC; Gunderson TM; Adjei AA; Go RS
    Lung Cancer; 2018 Aug; 122():214-219. PubMed ID: 30032834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association Between Treatment Facility Volume, Therapy Types, and Overall Survival in Patients With Stage IIIA Non-Small Cell Lung Cancer.
    Kommalapati A; Tella SH; Appiah AK; Smith L; Ganti AK
    J Natl Compr Canc Netw; 2019 Mar; 17(3):229-236. PubMed ID: 30865920
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Socioeconomic position, stage of lung cancer and time between referral and diagnosis in Denmark, 2001-2008.
    Dalton SO; Frederiksen BL; Jacobsen E; Steding-Jessen M; Østerlind K; Schüz J; Osler M; Johansen C
    Br J Cancer; 2011 Sep; 105(7):1042-8. PubMed ID: 21897390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.